What is the recommended approach for tapering or discontinuing baricitinib therapy in patients with alopecia areata who have achieved remission?
Featuring Karan Lal, DO, MS, FAAD | DO |
Director of Pediatric and Cosmetic Dermatology
Affiliated Dermatology
Scottsdale, AZ
Related CME
Related Media
Powered by Polaris TM